These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6281197)

  • 1. Differential cyst(e)ine requirements in human T and B lymphoblastoid cell lines.
    Kamatani N; Carson DA
    Int Arch Allergy Appl Immunol; 1982; 68(1):84-9. PubMed ID: 6281197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism.
    Brand K; Leibold W; Luppa P; Schoerner C; Schulz A
    Immunobiology; 1986 Oct; 173(1):23-34. PubMed ID: 3492437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant human diploid fibroblast clones able to grow in homocysteine in place of cyst(e)ine.
    Hankinson O; Jacoby LB
    Exp Cell Res; 1975 Nov; 96(1):138-44. PubMed ID: 172353
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppressor T cells activated by autologous B-cell derived lines inhibit blastogenic responses by peripheral lymphocytes to mitogens or autologous lymphoblastoid cell lines.
    Tsukuda K; Tsukuda Y; Klein G
    Cell Immunol; 1982 May; 69(2):291-304. PubMed ID: 6286150
    [No Abstract]   [Full Text] [Related]  

  • 5. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
    Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
    Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of mitogens on the expression of Epstein-Barr virus antigens in human lymphoid cell lines.
    Tovey MG; Lenoir G; Begon-Lours J; Tapiero H; Rochette-Egly C
    J Immunol; 1979 Jul; 123(1):138-42. PubMed ID: 221589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant human fibroblast clones able to grow on homocysteine instead of cyst(e)ine.
    Jacoby LB; Littlefield JW
    Exp Cell Res; 1971 Dec; 69(2):447-9. PubMed ID: 4360909
    [No Abstract]   [Full Text] [Related]  

  • 9. Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones.
    Gmünder H; Eck HP; Dröge W
    Eur J Biochem; 1991 Oct; 201(1):113-7. PubMed ID: 1680678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cyst(e)ine in the removal of protein-bound homocysteine.
    Smolin LA; Benevenga NJ
    Am J Clin Nutr; 1984 May; 39(5):730-7. PubMed ID: 6711475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytes.
    Kawano M; Matsushima K; Masuda A; Oppenheim JJ
    Cell Immunol; 1988 Feb; 111(2):273-86. PubMed ID: 2827895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A.
    Irving WL; Jenkins RE; Walker PR; Clayden SA; Lydyard PM
    Cell Immunol; 1985 Dec; 96(2):245-54. PubMed ID: 3017572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1-like activity produced by hybrids constructed with Epstein-Barr-virus-transformed human B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Pacciardi A; Tarantino E
    Int Arch Allergy Appl Immunol; 1988; 85(1):76-81. PubMed ID: 2828240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
    Tsukuda K; Berczi I; Klein G
    J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.